Sangamo Therapeutics, Inc.
IMPROVED CLINICAL PARAMETERS BY EXPRESSION OF FACTOR VIII
Last updated:
Abstract:
Described herein are constructs used for liver-specific expression of a transgene.
Status:
Application
Type:
Utility
Filling date:
2 Aug 2019
Issue date:
10 Jun 2021